Newsfeeds - Spark Newswire

1 minute read

Roth Capital Initiates Coverage On Research Solutions with Buy Rating, Announces Price Target of $4.35

Today, 1:01 PM

Roth Capital analyst Richard Baldry initiates coverage on Research Solutions (NASDAQ:RSSS) with a Buy rating and announces Price Target of $4.35.

RSSS

11 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 1:01 PM

This morning 143 companies set new 52-week highs.

ADBE

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 18, 2021

By Benzinga Insights

Today, 1:01 PM

ABMD

1 minute read

Maxim Group Initiates Coverage On Research Solutions with Buy Rating, Announces Price Target of $6

By Benzinga Newsdesk

Today, 1:01 PM

Maxim Group analyst Allen Klee initiates coverage on Research Solutions (NASDAQ:RSSS) with a Buy rating and announces Price Target of $6.

RSSS

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

By Benzinga Insights

Today, 1:01 PM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

Latest news

Roth Capital Initiates Coverage On Research Solutions with Buy Rating, Announces Price Target of $4.35

Stocks That Hit 52-Week Highs On Friday

Benzinga’s Top Ratings Upgrades, Downgrades For June 18, 2021

Maxim Group Initiates Coverage On Research Solutions with Buy Rating, Announces Price Target of $6

Earnings Scheduled For May 13, 2021